Dorward J, Yende-Zuma N, Samsunder N, Abdool Karim Q, Drain PK, Garrett N.
JAIDS 2018; 77(4):e36-e39. doi: 10.1097/QAI.0000000000001613.
Harichund C, Moshabela M.
AIDS and Behavior 2018; 22(2):560-568.
Montefiori DC, Roederer M, Morris L, Seaman MS.
Current Opinion in HIV and AIDS 2018; 13(2):128-136.
Serwanga J, Ssemwanga D, Muganga M, Nakiboneka R, Nakubulwa S, Kiwuwa-Muyingo S, Morris L, Redd AD, Quinn TC, Kaleebu P, HIV Superinfection Study Group.
Vaccine 2018; 36(4):578-586.
Reh L, Magnus C, Kadelka C, Kühnert D, Uhr T, Weber J, Morris L, Moore PL, Trkola A.
PLoS pathogens 2018; 14(1):e1006825. doi: 10.1371/journal.ppat.1006825.
Chikata T, Van Tran G, Murakoshi H, Akahoshi T, Qi Y, Naranbhai V, Kuse N, Tamura Y, Koyanagi M, Sakai S, Nguyen DH, Nguyen DT, Nguyen HT, Nguyen TV, Oka S, Martin MP, Carrington M, Sakai K, Van Nguyen K, Takiguchi M.
Journal of Viroloy 2018; 92(5). pii: e01749-17. doi: 10.1128/JVI.01749-17.
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.